GE shares surge 15% after Danaher agrees to buy biopharma business for $21.4 billion

Danaher will buy the biopharmaceutical business of General Electric in a $21.4 billion all cash deal, the companies announce.

https://www.cnbc.com/2019/02/25/danaher-to-buy-the-general-electrics-bio-pharma-business-life-sciences-for-21point4-billion.html